Pharma Journalist - Page 28 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

EU Invests €225M in Next-Generation Flu Vaccines

FDA Approves AbbVie’s Oral CLL Combination Regimen

VivaMed, Syngene Partner to Accelerate AI Drug Validation

Merck, Mayo Clinic Partner on AI Drug Development

Novartis Remibrutinib Shows Phase III Success in CIndU

Johnson & Johnson Reports Promising OrigAMI-4 Trial Results

Boehringer Ingelheim, NIPER Raebareli Sign Research MoU

Catalent, S.Biomedics Partner on Parkinson’s Cell Therapy

Johnson & Johnson Invests $1 Billion in Pennsylvania

Unnatural Products, Novartis Partner on Macrocyclic Therapies